Biochemical recurrence of prostate cancer – Parexel #245597

People with prostate cancer are asked to participate in a research study being conducted by Queens Hospital Center.

You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age
  • Previously took ADT, should be discontinued at least 16 weeks prior to screening
  • Are a patient with history of localized prostate cancer with prior curative treatment
  • Have an elevated prostate-specific antigen (PSA)

You may NOT participate in this study if you:

  • Have prior medical condition that may compromise data collection
  • Are currently receiving ADT
  • Are planning to have an x-ray prior to PET scan
  • Are participating in a clinical trial within 30 days of administration

Contact Information
Linda Bulone, Study Coordinator
82-68 164th Street Room A541 Jamaica, NY 11432
Phone: (718) 883-3751
Fax: (718) 883-6295